Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on Efficacy and Safety of CaReSR-1S to Repair Cartilage Defects of the Knee: a Randomised, Multicentre, Open-label, Controlled Trial

NCT03307668 is registered in ClinicalTrials.gov with Arthro-Anda Tianjin Biologic Technology Co., Ltd. as lead sponsor.

NCT NCT03307668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03307668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on Efficacy and Safety of CaReSR-1S to Repair Cartilage Defects of the Knee: a Randomised, Multicentre, Open-label, Controlled Trial
Lead sponsor
Arthro-Anda Tianjin Biologic Technology Co., Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2014
Completion date
December 31, 2019
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cartilage defects